Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, ...

Patients across the UK will take part in the study where their blood will be tested for a series of proteins - called ...

Researchers have determined that healthcare providers increased their ability to make Alzheimer’s disease (AD) probability judgments on their patients when they used the PrecivityAD2™ blood biomarker ...

Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its ...

People with shorter protective caps at the end of their chromosomes (called telomeres) may be more likely to develop ...

“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...

There is, thus, a need for basic science and clinical research on blood-based cellular and molecular biomarkers to diagnose stroke type quickly, restore cerebral circulation, modulate hemorrhage ...

Although these approaches can detect brain pathology at early disease stages, blood-based biomarkers are emerging as accessible alternatives. Moreover, research has expanded the understanding of ...

Prenatal exposure to neuroinflammation (cytokines) may provide a biomarker for the risk of later development of Alzheimer's ...

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.